Abridge was founded in 2018 to power deeper understanding in healthcare. The enterprise-grade AI platform transforms medical conversations into clinically useful and billable documentation at the point of care, reducing administrative burden and clinician burnout while improving patient experience. With deep EHR integration, support for 28+ languages, and 50+ specialties, Abridge is used across a wide range of care settings, including outpatient, emergency department, and inpatient.
Abridge’s enterprise-grade AI platform is purpose-built for healthcare. Supported by Linked Evidence, Abridge’s solution that maps AI-generated summaries to source data, helping clinicians quickly trust and verify the output. As a pioneer in generative AI for healthcare, Abridge sets a high industry standard for the responsible deployment of AI across health systems.
Abridge was recently awarded Best in KLAS for Ambient AI segment in addition to other accolades, including TIME Best Inventions of 2024, 2024 Forbes AI 50 List, and Fortune’s 2024 AI 50 Innovators.
“We are privileged to partner with AMIA and support their initiatives to create engaging forums about healthcare informatics,” said Dr. Shiv Rao, CEO and Founder. “As AI platforms like Abridge are implemented across large health systems, efforts from organizations like AMIA will be critical to ensure AI is adopted and deployed responsibly.”
Resources
- Enterprise-Grade AI: The Abridge Generative AI Platform for Clinical Conversations
- Abridge in Action: Sutter Health Case Study Shows Improved Clinician Satisfaction
- Healthcare AI Research: Pioneering the Science of AI
- Evaluation Investment in AI: Abridge Announces $250 Million Series D and New Contextual Reasoning Engine
- Fortune Profile: Dr. Shiv Rao, Abridge Founder and CEO
